Patheon’s highly skilled team of Pharmaceutical Development Services (PDS) scientists have proven ability to bring new customer products through the development process and have successfully launched more than 19 new NDA products* since 20011.
In fact, seven of the customer products launched by Patheon PDS were among the top 200 selling Rx drugs in the world2.
We would be happy to assist you with the development and launch of your new molecule in substantially any dosage form in most global markets.
Sources:
1 As at fiscal year end (October 31, 2007)
2 MedAd News, Top 500 Prescription Drugs, June 2007
*or equivalent filings